Patheon to Host Q3 2008 Financial Results Conference Call and Webcast

    TORONTO, Aug. 21 /CNW/ - Patheon Inc. (TSX: PTI) will host a conference
call with financial analysts on Friday, September 5, 2008 at 10:00 a.m. (EST)
to discuss its third quarter 2008 financial results. The third quarter
financial results news release will be issued at approximately 7:00 a.m. (EST)
on Friday, September 5, 2008.
    Interested parties are invited to access the live call, via telephone, in
listen-only mode, at (416) 644-3414 (Toronto and International) or toll free
at (800) 733-7571 (U.S., including Puerto Rico). Listeners are encouraged to
dial in five to 15 minutes in advance to avoid delays. A live audio webcast
will also be available via the web at (Please note that
Windows Media Player or RealPlayer is required.)
    A telephone replay of the conference call will be available between
Friday, September 5, 2008 and Friday, September 12, 2008 by calling (416)
640-1917 or (877) 289-8525 (toll free) and entering identification number
21280762, followed by the number key. The webcast will also be archived on for three months.


    Patheon Inc. (TSX:PTI; is a leading global provider of
contract development and manufacturing services to the global pharmaceutical
industry. Patheon prides itself in providing the highest quality products and
services to more than 300 of the world's leading pharmaceutical and
biotechnology companies. Patheon's services range from preclinical development
through commercial manufacturing of a full array of dosage forms including
parenteral, solid, semi-solid and liquid forms. Patheon uses many innovative
technologies including single-use disposables, Liquid-Filled Hard Capsules and
a variety of modified release technologies.
    Patheon's comprehensive range of fully integrated Pharmaceutical
Development Services includes pre-formulation, formulation, analytical
development, clinical manufacturing, scale-up and commercialization. Patheon
can take customers direct to clinic with global clinical packaging and
distribution services and Patheon's Quick to Clinic(TM) programs can
accelerate early phase development project to clinical trials while minimizing
the consumption of valuable API.
    Patheon's integrated development and manufacturing network of 11
facilities, and 6 development centers across North America and Europe, strives
to ensure that customer products can be launched with confidence anywhere in
the world.

    Caution Concerning Forward-Looking Statements

    This news release may contain forward-looking statements which reflect
management's expectations regarding the Company's future growth of operations,
performance (both operational and financial) and business prospects and
opportunities. These statements are made in the context of the risks and
uncertainties that are outlined in the Company's public documents, which can
be accessed on our website at or on SEDAR at

    %SEDAR: 00001700E

For further information:

For further information: Mr. Wes Wheeler, President & Chief Executive
Officer, Tel: (905) 812-2112, Email:; Mr. Eric Evans,
Chief Financial Officer, Tel: (905) 812-6660, Email:;
Ms. Jean Treadwell, Investor Relations, Tel: (905) 816-8344, Email:

Organization Profile

Patheon Inc

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890